These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39430127)
1. The senolytic agent ABT263 ameliorates osteoporosis caused by active vitamin D insufficiency through selective clearance of senescent skeletal cells. Yang C; Qiao W; Xue Q; Goltzman D; Miao D; Dong Z J Orthop Translat; 2024 Nov; 49():107-118. PubMed ID: 39430127 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D insufficiency accelerates age-related bone loss by increasing oxidative stress and cell senescence. Qiao W; Yu S; Sun H; Chen L; Wang R; Wu X; Goltzman D; Miao D Am J Transl Res; 2020; 12(2):507-518. PubMed ID: 32194899 [TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis. Yang R; Chen J; Zhang J; Qin R; Wang R; Qiu Y; Mao Z; Goltzman D; Miao D Aging Cell; 2020 Feb; 19(2):e13095. PubMed ID: 31880094 [TBL] [Abstract][Full Text] [Related]
4. The Polycomb Protein Bmi1 Plays a Crucial Role in the Prevention of 1,25(OH) Sun H; Qiao W; Cui M; Yang C; Wang R; Goltzman D; Jin J; Miao D J Bone Miner Res; 2020 Mar; 35(3):583-595. PubMed ID: 31725940 [TBL] [Abstract][Full Text] [Related]
5. The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice. Sharma AK; Roberts RL; Benson RD; Pierce JL; Yu K; Hamrick MW; McGee-Lawrence ME Front Cell Dev Biol; 2020; 8():354. PubMed ID: 32509782 [TBL] [Abstract][Full Text] [Related]
6. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss. Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351 [TBL] [Abstract][Full Text] [Related]
7. Peptide-Amphiphilic Nanoassemblies as a Responsive Senolytic Navigator for Targeted Removal of Senescent Cardiomyocytes to Ameliorate Heart Failure. Wu Z; Zeng Y; Chen H; Xiao Z; Guo J; Abubakar MN; Shen M; Xiao H; Song X; Cai Y ACS Appl Mater Interfaces; 2024 Sep; 16(38):50282-50294. PubMed ID: 39268787 [TBL] [Abstract][Full Text] [Related]
8. Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis. Yang H; Chen C; Chen H; Duan X; Li J; Zhou Y; Zeng W; Yang L Aging (Albany NY); 2020 Jul; 12(13):12750-12770. PubMed ID: 32611834 [TBL] [Abstract][Full Text] [Related]
9. [Senolytic effects on dental pulp stem cell's proliferation and differentiation during long-term expansion]. Wang GY; Liao L; Tian WD Zhonghua Kou Qiang Yi Xue Za Zhi; 2024 May; 59(5):444-452. PubMed ID: 38636998 [No Abstract] [Full Text] [Related]
10. Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells. Pungsrinont T; Sutter MF; Ertingshausen MCCM; Lakshmana G; Kokal M; Khan AS; Baniahmad A Cell Biosci; 2020; 10():59. PubMed ID: 32351687 [TBL] [Abstract][Full Text] [Related]
11. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells. Murakami T; Inagaki N; Kondoh H Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205 [TBL] [Abstract][Full Text] [Related]
12. Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans. Farr JN; Rowsey JL; Eckhardt BA; Thicke BS; Fraser DG; Tchkonia T; Kirkland JL; Monroe DG; Khosla S J Bone Miner Res; 2019 Aug; 34(8):1407-1418. PubMed ID: 30913313 [TBL] [Abstract][Full Text] [Related]
13. The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Hambright WS; Mu X; Gao X; Guo P; Kawakami Y; Mitchell J; Mullen M; Nelson AL; Bahney C; Nishimura H; Hellwinkel J; Eck A; Huard J J Osteoporos; 2023; 2023():5572754. PubMed ID: 36875869 [TBL] [Abstract][Full Text] [Related]
14. Radiation-Induced Osteocyte Senescence Alters Bone Marrow Mesenchymal Stem Cell Differentiation Potential via Paracrine Signaling. Xu L; Wang Y; Wang J; Zhai J; Ren L; Zhu G Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502232 [TBL] [Abstract][Full Text] [Related]
15. Depletion of SASP senescent cardiomyocytes with senolytic drugs confers therapeutic effects in doxorubicin-related cardiotoxicity. Xia W; Chen H; Yang H; Zhu L; Xie C; Hou M FEBS J; 2024 Sep; 291(18):4029-4042. PubMed ID: 38857187 [TBL] [Abstract][Full Text] [Related]
16. Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis. Su W; Hu Y; Fan X; Xie J Int Immunopharmacol; 2023 Feb; 115():109694. PubMed ID: 36638657 [TBL] [Abstract][Full Text] [Related]
17. Tryptanthrin targets GSTP1 to induce senescence and increases the susceptibility to apoptosis by senolytics in liver cancer cells. Zhang Y; Xiao B; Yuan S; Ding L; Pan Y; Jiang Y; Sun S; Ke X; Cai L; Jia L Redox Biol; 2024 Oct; 76():103323. PubMed ID: 39180983 [TBL] [Abstract][Full Text] [Related]